Question 1

What are the potential benefits of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the ECT in Ultra-resistant Schizophrenia clinical trial (NCT03542903). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the ECT sessions be scheduled and what can I expect during each session?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the ECT in Ultra-resistant Schizophrenia clinical trial (NCT03542903). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of from the ECT treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the ECT in Ultra-resistant Schizophrenia clinical trial (NCT03542903). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored throughout the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the ECT in Ultra-resistant Schizophrenia clinical trial (NCT03542903). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any risks associated with the medications used during the ECT?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the ECT in Ultra-resistant Schizophrenia clinical trial (NCT03542903). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience a relapse after the treatment ends?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the ECT in Ultra-resistant Schizophrenia clinical trial (NCT03542903). Contact the study team or your healthcare provider for specific answers.

What this study is about